SCHEMBL16477032

SCHEMBL16477032

Cc1noc(-c2ccc(-c3ccc4c(c3)CCOC4)cc2)c1NC(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR1 Q92633 5/20 0.47
LPAR3 Q9UBY5 3/20 0.44
LPAR2 Q9HBW0 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
ABCC3 O15438 1/20 0.43
ABCC4 O15439 1/20 0.43
ABCB11 O95342 1/20 0.43
CYP2C8 P10632 1/20 0.43
CYP2C9 P11712 1/20 0.43
ABCB4 P21439 1/20 0.43
ABCC2 Q92887 1/20 0.43
SLCO1B3 Q9NPD5 1/20 0.43
SLCO1B1 Q9Y6L6 1/20 0.43
MGLL Q99685 3/20 0.41
ROCK2 O75116 1/20 0.39
ENPP2 Q13822 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16479855 0.83 LPAR1 (0.44) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL4029141 0.82 LPAR1 (0.62) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL16477034 0.80 LPAR1 (0.68) LPAR1LPAR3LPAR2ABCC3ABCC4
SCHEMBL343051 0.79 LPAR1 (0.56) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL343594 0.77 LPAR1 (0.69) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL16477041 0.76 LPAR1 (0.73) LPAR1LPAR3LPAR2ABCC3ABCC4
SCHEMBL28398519 0.76 LPAR1 (0.49) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL342658 0.75 LPAR1 (0.59) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL16477186 0.74 LPAR1 (0.53) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3
SCHEMBL15897074 0.73 LPAR1 (0.48) LPAR1LPAR3LPAR2SMN1; SMN2ABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140200215-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. 2014-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200215-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS LPAR1, LPAR2, LPAR5 LPAR1 1/4885LPAR3 5/4885LPAR2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.